DE602004022169D1 - Tetrahydrocarbazolderivate und deren pharmazeutische verwendung - Google Patents
Tetrahydrocarbazolderivate und deren pharmazeutische verwendungInfo
- Publication number
- DE602004022169D1 DE602004022169D1 DE602004022169T DE602004022169T DE602004022169D1 DE 602004022169 D1 DE602004022169 D1 DE 602004022169D1 DE 602004022169 T DE602004022169 T DE 602004022169T DE 602004022169 T DE602004022169 T DE 602004022169T DE 602004022169 D1 DE602004022169 D1 DE 602004022169D1
- Authority
- DE
- Germany
- Prior art keywords
- tetrahydrocarbazol
- derivatives
- pharmaceutical use
- pharmaceutical
- tetrahydrocarbazol derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical class N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47797203P | 2003-06-12 | 2003-06-12 | |
US49778703P | 2003-08-26 | 2003-08-26 | |
PCT/US2004/018180 WO2005005386A1 (en) | 2003-06-12 | 2004-06-07 | Tetrahydrocarbazole derivatives and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004022169D1 true DE602004022169D1 (de) | 2009-09-03 |
Family
ID=34068099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004022169T Expired - Lifetime DE602004022169D1 (de) | 2003-06-12 | 2004-06-07 | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung |
Country Status (15)
Country | Link |
---|---|
US (1) | US7419997B2 (de) |
EP (1) | EP1646610B1 (de) |
JP (1) | JP2007500750A (de) |
KR (1) | KR20060017544A (de) |
AU (1) | AU2004256052A1 (de) |
BR (1) | BRPI0411245A (de) |
CA (1) | CA2528336A1 (de) |
CO (1) | CO5660264A2 (de) |
DE (1) | DE602004022169D1 (de) |
ES (1) | ES2327416T3 (de) |
IL (1) | IL172087A0 (de) |
MA (1) | MA27879A1 (de) |
NO (1) | NO20055750L (de) |
RU (1) | RU2005138126A (de) |
WO (1) | WO2005005386A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1678137A1 (de) * | 2003-10-15 | 2006-07-12 | Chiron Corporation | Zusammensetzungen und verfahren zur inhibierung von viren |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
CA2559408C (en) | 2004-03-15 | 2014-05-13 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the inhibition of angiogenesis |
WO2006012310A2 (en) * | 2004-06-25 | 2006-02-02 | Genzyme Corporation | Carbazole derivatives for treating polycystic kidney disease |
US20090170906A1 (en) * | 2004-11-22 | 2009-07-02 | Kristjan Gudmundsson | Hcv inhibitors |
MX2007006178A (es) | 2004-11-23 | 2007-06-20 | Ptc Therapeutics Inc | Fenoles substituidos como agentes activos que inhiben la produccion del factor de crecimiento endotelial vascular. |
WO2019005841A1 (en) * | 2017-06-26 | 2019-01-03 | Rutgers, The State University Of New Jersey | THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION |
US10882821B1 (en) | 2017-09-26 | 2021-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9008108D0 (en) | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
GB0015904D0 (en) * | 2000-06-28 | 2000-08-23 | Hoffmann La Roche | Inhibitors of HPV E1 helicase enzyme |
DE10164564B4 (de) | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR) |
-
2004
- 2004-06-07 WO PCT/US2004/018180 patent/WO2005005386A1/en active Application Filing
- 2004-06-07 CA CA002528336A patent/CA2528336A1/en not_active Abandoned
- 2004-06-07 AU AU2004256052A patent/AU2004256052A1/en not_active Abandoned
- 2004-06-07 JP JP2006533613A patent/JP2007500750A/ja active Pending
- 2004-06-07 EP EP04776370A patent/EP1646610B1/de not_active Expired - Lifetime
- 2004-06-07 BR BRPI0411245-8A patent/BRPI0411245A/pt not_active IP Right Cessation
- 2004-06-07 RU RU2005138126/04A patent/RU2005138126A/ru not_active Application Discontinuation
- 2004-06-07 KR KR1020057023780A patent/KR20060017544A/ko not_active Application Discontinuation
- 2004-06-07 US US10/560,016 patent/US7419997B2/en not_active Expired - Fee Related
- 2004-06-07 ES ES04776370T patent/ES2327416T3/es not_active Expired - Lifetime
- 2004-06-07 DE DE602004022169T patent/DE602004022169D1/de not_active Expired - Lifetime
-
2005
- 2005-11-21 IL IL172087A patent/IL172087A0/en unknown
- 2005-12-05 NO NO20055750A patent/NO20055750L/no not_active Application Discontinuation
- 2005-12-09 MA MA28645A patent/MA27879A1/fr unknown
- 2005-12-15 CO CO05126691A patent/CO5660264A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20055750L (no) | 2006-01-06 |
MA27879A1 (fr) | 2006-05-02 |
ES2327416T3 (es) | 2009-10-29 |
CA2528336A1 (en) | 2005-01-20 |
WO2005005386A1 (en) | 2005-01-20 |
US7419997B2 (en) | 2008-09-02 |
BRPI0411245A (pt) | 2006-07-18 |
KR20060017544A (ko) | 2006-02-23 |
RU2005138126A (ru) | 2006-07-27 |
CO5660264A2 (es) | 2006-07-31 |
JP2007500750A (ja) | 2007-01-18 |
IL172087A0 (en) | 2009-02-11 |
NO20055750D0 (no) | 2005-12-05 |
EP1646610B1 (de) | 2009-07-22 |
US20060148857A1 (en) | 2006-07-06 |
AU2004256052A1 (en) | 2005-01-20 |
EP1646610A1 (de) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
ATE370958T1 (de) | Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung | |
DE60138768D1 (de) | Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln | |
DE60226704D1 (de) | Acylierte 6,7,8,9-tetrahydro-5h-benzocycloheptenyl-amine und deren pharmazeutische verwendung | |
DE602004021904D1 (de) | Gyraseinhibitoren und deren verwendungen | |
DE60208351D1 (de) | Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung | |
DE60237580D1 (de) | Glykopyranosyloxypyrazolderivate und deren medizinische verwendung | |
ATE395342T1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
ATE524178T1 (de) | Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel | |
DE602005002470D1 (de) | 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung | |
ATE459647T1 (de) | Humane il-18 substitutionsmutanten und deren konjugate | |
ATA13842001A (de) | Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung | |
ATE517081T1 (de) | Hydroxamsäureester und deren pharmazeutische verwendung | |
DE60332393D1 (de) | Flüssige pharmazeutische zusammensetzung mit pyridonderivaten | |
DE60323754D1 (de) | Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung | |
DE602004027354D1 (de) | SUBSTITUIERTE 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON- UND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATE UND DEREN VERWENDUNG BEI NEURODEGENERATIVEN KRANKHEITEN | |
IL172087A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
ATE555097T1 (de) | 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente | |
DE50206476D1 (de) | Cyanoanthranylamid-derivate und deren verwendung als arzneimittel | |
DE602005012287D1 (de) | Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung | |
ATE371653T1 (de) | Benzoxazinderivate und deren verwendungen | |
ATE517104T1 (de) | Beta-carbolinderivate und deren pharmazeutische verwendung gegen depression und angst | |
DE60336720D1 (de) | Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten | |
DE602004030564D1 (de) | 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |